|
|
||||||||
Department of Virology, Faculty of Medicine, Kyushu University, Fukuoka, 812-8582, Japan
Correspondence
Yusuke Yanagi
yyanagi{at}virology.med.kyushu-u.ac.jp
Signalling lymphocyte activation molecule (SLAM, also known as CD150), a membrane glycoprotein involved in lymphocyte activation, has two extracellular immunoglobulin superfamily domains, V and C2. It has been shown previously that human SLAM is a cellular receptor for measles virus (MV) and that its V domain is necessary and sufficient for receptor function. Although mouse SLAM has functional and structural similarity to human SLAM, it hardly acts as a receptor for MV. By producing human/mouse chimeric molecules and assessing their receptor function with a vesicular stomatitis virus pseudotype assay, the region at amino acid positions 5867 was found to be critically responsible for the difference in MV receptor function between human and mouse SLAMs. Exchange of this region allowed mouse SLAM to act as a receptor for MV, almost comparable to human SLAM. Among three amino acid differences (positions 60, 61 and 63) in this region, histidine 61 present in human SLAM was most significant, but combined substitutions with this residue and one or both of isoleucine 60 and valine 63 increased further the receptor activity of mouse SLAM. On the other hand, converse substitution at position 61 compromised receptor function of human SLAM. Thus, histidine 61 and its adjacent residues at positions 60 and 63 are critical for SLAM to act as a receptor for MV. Notably, the pseudotype assay indicated that residues at these three positions are also critical for the function of SLAM as a receptor for canine distemper virus.
This article has been cited by other articles:
![]() |
T. Hashiguchi, M. Kajikawa, N. Maita, M. Takeda, K. Kuroki, K. Sasaki, D. Kohda, Y. Yanagi, and K. Maenaka Crystal structure of measles virus hemagglutinin provides insight into effective vaccines PNAS, December 4, 2007; 104(49): 19535 - 19540. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yanagi, M. Takeda, and S. Ohno Measles virus: cellular receptors, tropism and pathogenesis. J. Gen. Virol., October 1, 2006; 87(Pt 10): 2767 - 2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Sellin, N. Davoust, V. Guillaume, D. Baas, M.-F. Belin, R. Buckland, T. F. Wild, and B. Horvat High Pathogenicity of Wild-Type Measles Virus Infection in CD150 (SLAM) Transgenic Mice. J. Virol., July 1, 2006; 80(13): 6420 - 6429. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. von Messling, D. Milosevic, P. Devaux, and R. Cattaneo Canine Distemper Virus and Measles Virus Fusion Glycoprotein Trimers: Partial Membrane-Proximal Ectodomain Cleavage Enhances Function J. Virol., August 1, 2004; 78(15): 7894 - 7903. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vongpunsawad, N. Oezgun, W. Braun, and R. Cattaneo Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural Model J. Virol., January 1, 2004; 78(1): 302 - 313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |